Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development and Evaluation of Computerized Olfactory Training Program (COT) for Cognitive Decline in Early Alzheimer's Disease (AD)

NCT05122598 is registered in ClinicalTrials.gov with Evon Medics LLC as lead sponsor.

NCT NCT05122598
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05122598 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development and Evaluation of Computerized Olfactory Training Program (COT) for Cognitive Decline in Early Alzheimer's Disease (AD)
Lead sponsor
Evon Medics LLC
Phase
Phase 2
Overall status
Unknown status
Start date
November 15, 2021
Completion date
April 30, 2023
Enrollment
200 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

early alzheimer's disease, memory impairment, mild cognitive impairment